Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 19, 2009, Pages 7933-7938

  Lou, Hong ^a,b   Yeager, Meredith ^b,c   Li, Hongchuan ^a   Bosquet, Jesus Gonzalez ^c   Hayes, Richard B ^c   Orr, Nick ^c   Yu, Kai ^c   Hutchinson, Amy ^b,c   Jacobs, Kevin B ^d   Kraft, Peter ^e   Wacholder, Sholom ^c   Chatterjee, Nilanjan ^c   Feigelson, Heather Spencer ^f   Thun, Michael J ^f   Diver, W Ryan ^f   Albanes, Demetrius ^c   Virtamo, Jarmo ^e   Weinstein, Stephanie ^c   Ma, Jing ^g   Gaziano, J Michael ^h   Stampfer, Meir ^g   Schumacher, Fredrick R ^e,g   Giovannucci, Edward ^h   Cancel Tassin, Geraldine ⁱ   Cussenot, Olivier ⁱ   Valeri, Antoine ⁱ   Andriole, Gerald L ^j   Crawford, E David ^k   Anderson, Stephen K ^a   Tucker, Margaret ^c   Hoover, Robert N ^c   Fraumeni Jr , Joseph F ^c   Thomas, Gilles ^d   Hunter, David J ^e   Dean, Michael ^a   Chanock, Stephen J ^c   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Bioinformed Consulting Services   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f AMERICAN CANCER SOCIETY   (United States)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

CREB transcription factor; Genome wide association studies; Prostate cancer genetics

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 10; CONTROLLED STUDY; EXON; FOLLOW UP; GENE; GENE EXPRESSION; GENE FUNCTION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HAPLOTYPE MAP; HETEROZYGOTE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MSMB GENE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE;

ALLELES; CELL LINE, TUMOR; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME; HETEROZYGOTE; HUMANS; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS;

EID: 66049160161     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0902104106     Document Type: Article

References (27)

1. Crawford ED (2003) Epidemiology of prostate cancer. Urology 62:3-12. (Pubitemid 38050194)
2. Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91:789-794. (Pubitemid 36724060)
3. Schaid DJ (2004) The complex genetic epidemiology of prostate cancer. Hum Mol Genet 13(Spec No 1):R103-R121. (Pubitemid 38443804)
4. Carlson CS, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74:106-120. (Pubitemid 38085242)
5. Chanock SJ, et al. (2007) Replicating genotype-phenotype associations. Nature 447:655-660. (Pubitemid 46889722)
6. Manolio TA, Brooks LD, Collins FS (2008) A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118:1590-1605.
7. Eeles RA, et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40:316-321.
8. Amundadottir LT, et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38:652-658. (Pubitemid 43927306)
9. Freedman ML, et al. (2006) Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA 103:14068-14073. (Pubitemid 44452981)
10. Gudmundsson J, et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39:631-637. (Pubitemid 46676102)
11. Gudmundsson J, et al. (2007) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39:977-983. (Pubitemid 47185170)
12. Haiman CA, et al. (2007) A common genetic risk factor for colorectal and prostate cancer. Nat Genet 39:954-956. (Pubitemid 47185184)
13. Haiman CA, et al. (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 39:638-644. (Pubitemid 46676106)
14. Thomas G, et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40:310-315.
15. Yeager M, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39:645-649. (Pubitemid 46676108)
16. Mbikay M, et al. (1987) Molecular cloning and sequence of the cDNA for a 94-amino-acid seminal plasma protein secreted by the human prostate. DNA Cell Biol 6:23-29. (Pubitemid 17033549)
17. Bjartell AS, et al. (2007) Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy. Clin Cancer Res 13:4130-4138.
18. Reeves JR, Dulude H, Panchal C, Daigneault L, Ramnani DM (2006) Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy. Clin Cancer Res 12:6018-6022.
19. Beke L, Nuytten M, Van Eynde A, Beullens M, Bollen M (2007) The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2. Oncogene 26:4590-4595. (Pubitemid 47037047)
20. LaTulippe E, et al. (2002) Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 62:4499-4506.
21. Vanaja DK, Cheville JC, Iturria SJ, Young CY (2003) Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Res 63:3877-3882. (Pubitemid 36917897)
22. Stanbrough M, et al. (2006) Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 66:2815-2825.
23. Buckland PR, et al. (2005) Strong bias in the location of functional promoter polymorphisms. Hum Mutat 26:214-223. (Pubitemid 41254377)
24. Chang BL, et al. (2009). Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet 18:1368-1375.
25. Yeager M, et al. (2008) Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers. Hum Genet 124:161-170.
26. Ma J, et al. (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: A long-term survival analysis. Lancet Oncol 9:1039-1047.
27. Packer BR, et al. (2006) SNP500Cancer: A public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 34:D617-D621.